Akkerman EM - Search Results

1

Sequential MR imaging changes in nonketotic hyperglycinemia.

Mourmans J, Majoie CB, Barth PG, Duran M, Akkerman EM, Poll-The BT. Mourmans J, et al. Among authors: akkerman em. AJNR Am J Neuroradiol. 2006 Jan;27(1):208-11. AJNR Am J Neuroradiol. 2006. PMID: 16418385 Free PMC article.

2

Evaluation of the occlusion status of coiled intracranial aneurysms with MR angiography at 3T: is contrast enhancement necessary?

Sprengers ME, Schaafsma JD, van Rooij WJ, van den Berg R, Rinkel GJ, Akkerman EM, Ferns SP, Majoie CB. Sprengers ME, et al. Among authors: akkerman em. AJNR Am J Neuroradiol. 2009 Oct;30(9):1665-71. doi: 10.3174/ajnr.A1678. Epub 2009 Jul 23. AJNR Am J Neuroradiol. 2009. PMID: 19628623 Free PMC article. Clinical Trial.

3

MR spectroscopy findings in early stages of motor neuron disease.

van der Graaff MM, Lavini C, Akkerman EM, Majoie ChB, Nederveen AJ, Zwinderman AH, Brugman F, van den Berg LH, de Jong JM, de Visser M. van der Graaff MM, et al. Among authors: akkerman em. AJNR Am J Neuroradiol. 2010 Nov;31(10):1799-806. doi: 10.3174/ajnr.A2217. Epub 2010 Aug 26. AJNR Am J Neuroradiol. 2010. PMID: 20801763 Free PMC article. Clinical Trial.

4

Uniform fat suppression in hands and feet through the use of two-point Dixon chemical shift MR imaging.

Maas M, Dijkstra PF, Akkerman EM. Maas M, et al. Among authors: akkerman em. Radiology. 1999 Jan;210(1):189-93. doi: 10.1148/radiology.210.1.r99ja35189. Radiology. 1999. PMID: 9885606

5

Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned.

van Dussen L, Akkerman EM, Hollak CE, Nederveen AJ, Maas M. van Dussen L, et al. Among authors: akkerman em. J Inherit Metab Dis. 2014 Nov;37(6):1003-11. doi: 10.1007/s10545-014-9726-3. Epub 2014 Jun 13. J Inherit Metab Dis. 2014. PMID: 24924293 Review.

6

MRI in clinically asymptomatic neuropathic leprosy feet: a baseline study.

Maas M, Slim EJ, Akkerman EM, Faber WR. Maas M, et al. Among authors: akkerman em. Int J Lepr Other Mycobact Dis. 2001 Sep;69(3):219-24. Int J Lepr Other Mycobact Dis. 2001. PMID: 11875766

7

Radiology of Gaucher disease (type 1) and bone manifestations: the Dutch experience.

Maas M, Hollak CE, Akkerman EM, Aerts JF. Maas M, et al. Among authors: akkerman em. JBR-BTR. 2006 Nov-Dec;89(6):318-21. JBR-BTR. 2006. PMID: 17274590

8

Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.

Hollak C, Maas M, Akkerman E, den Heeten A, Aerts H. Hollak C, et al. Blood Cells Mol Dis. 2001 Nov-Dec;27(6):1005-12. doi: 10.1006/bcmd.2001.0474. Blood Cells Mol Dis. 2001. PMID: 11831867

9

Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers.

Maas M, Akkerman EM, Venema HW, Stoker J, Den Heeten GJ. Maas M, et al. Among authors: akkerman em. J Comput Assist Tomogr. 2001 Sep-Oct;25(5):691-7. doi: 10.1097/00004728-200109000-00005. J Comput Assist Tomogr. 2001. PMID: 11584227 Clinical Trial.

10

Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease.

van Dussen L, Zimran A, Akkerman EM, Aerts JM, Petakov M, Elstein D, Rosenbaum H, Aviezer D, Brill-Almon E, Chertkoff R, Maas M, Hollak CE. van Dussen L, et al. Among authors: akkerman em. Blood Cells Mol Dis. 2013 Mar;50(3):206-11. doi: 10.1016/j.bcmd.2012.11.001. Epub 2012 Nov 28. Blood Cells Mol Dis. 2013. PMID: 23199589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters